News & verdicts
Every headline of the morning round of Thursday, August 6 — every verdict, including the noise. One row per (stock × article); model columns in panel order, anchor first.
- afternoon round · Aug 7 · 689 articles · 398 yes / 203 no →
- morning round · Aug 7 · 623 articles · 373 yes / 284 no →
- afternoon round · Aug 6 · 676 articles · 368 yes / 239 no →
- morning round · Aug 6 · 537 articles · 381 yes / 272 no
- afternoon round · Aug 5 · 667 articles · 403 yes / 203 no →
- morning round · Aug 5 · 668 articles · 437 yes / 283 no →
- afternoon round · Aug 4 · 760 articles · 389 yes / 285 no →
- morning round · Aug 4 · 625 articles · 432 yes / 275 no →
- afternoon round · Aug 3 · 727 articles · 415 yes / 225 no →
- morning round · Aug 3 · 545 articles · 357 yes / 221 no →
- afternoon round · Jul 31 · 705 articles · 402 yes / 231 no →
- morning round · Jul 31 · 579 articles · 390 yes / 261 no →
- afternoon round · Jul 30 · 741 articles · 485 yes / 206 no →
- morning round · Jul 30 · 528 articles · 445 yes / 249 no →
- afternoon round · Jul 29 · 738 articles · 398 yes / 287 no →
- morning round · Jul 29 · 587 articles · 435 yes / 237 no →
- afternoon round · Jul 28 · 721 articles · 328 yes / 338 no →
- morning round · Jul 28 · 621 articles · 441 yes / 263 no →
- afternoon round · Jul 27 · 724 articles · 372 yes / 261 no →
- morning round · Jul 27 · 568 articles · 373 yes / 243 no →
- afternoon round · Jul 24 · 661 articles · 363 yes / 190 no →
- morning round · Jul 24 · 779 articles · 320 yes / 364 no →
- afternoon round · Jul 23 · 790 articles · 379 yes / 265 no →
- morning round · Jul 23 · 804 articles · 430 yes / 282 no →
- afternoon round · Jul 22 · 688 articles · 366 yes / 217 no →
- morning round · Jul 22 · 748 articles · 395 yes / 250 no →
- afternoon round · Jul 21 · 767 articles · 426 yes / 217 no →
- morning round · Jul 21 · 693 articles · 383 yes / 254 no →
- afternoon round · Jul 20 · 751 articles · 348 yes / 233 no →
- morning round · Jul 20 · 593 articles · 358 yes / 234 no →
- afternoon round · Jul 17 · 657 articles · 306 yes / 250 no →
- morning round · Jul 17 · 660 articles · 287 yes / 267 no →
- afternoon round · Jul 16 · 742 articles · 342 yes / 226 no →
- morning round · Jul 16 · 745 articles · 389 yes / 268 no →
- afternoon round · Jul 15 · 694 articles · 353 yes / 210 no →
- morning round · Jul 15 · 716 articles · 394 yes / 231 no →
- afternoon round · Jul 14 · 698 articles · 335 yes / 246 no →
- morning round · Jul 14 · 734 articles · 453 yes / 237 no →
- afternoon round · Jul 13 · 658 articles · 349 yes / 170 no →
- morning round · Jul 13 · 544 articles · 375 yes / 207 no →
- afternoon round · Jul 10 · 577 articles · 331 yes / 220 no →
- morning round · Jul 10 · 673 articles · 333 yes / 239 no →
- afternoon round · Jul 9 · 638 articles · 379 yes / 199 no →
- morning round · Jul 9 · 681 articles · 323 yes / 299 no →
- afternoon round · Jul 8 · 696 articles · 365 yes / 282 no →
- morning round · Jul 8 · 684 articles · 344 yes / 314 no →
- afternoon round · Jul 7 · 652 articles · 353 yes / 225 no →
- morning round · Jul 7 · 623 articles · 397 yes / 223 no →
- afternoon round · Jul 6 · 750 articles · 360 yes / 231 no →
- morning round · Jul 6 · 565 articles · 365 yes / 224 no →
- afternoon round · Jul 3 · 227 articles · 37 yes / 102 no →
- afternoon round · Jul 2 · 712 articles · 579 yes / 369 no →
- morning round · Jul 2 · 641 articles · 548 yes / 409 no →
- afternoon round · Jul 1 · 711 articles · 557 yes / 336 no →
- morning round · Jul 1 · 654 articles · 504 yes / 466 no →
- afternoon round · Jun 30 · 726 articles · 608 yes / 315 no →
- morning round · Jun 30 · 691 articles · 521 yes / 358 no →
- afternoon round · Jun 29 · 695 articles · 578 yes / 312 no →
- morning round · Jun 29 · 520 articles · 547 yes / 349 no →
- afternoon round · Jun 26 · 679 articles · 624 yes / 359 no →
- morning round · Jun 26 · 684 articles · 466 yes / 420 no →
- afternoon round · Jun 25 · 728 articles · 562 yes / 422 no →
- morning round · Jun 25 · 594 articles · 591 yes / 306 no →
- afternoon round · Jun 24 · 677 articles · 572 yes / 246 no →
- morning round · Jun 24 · 763 articles · 557 yes / 420 no →
- afternoon round · Jun 23 · 701 articles · 522 yes / 422 no →
- morning round · Jun 23 · 631 articles · 473 yes / 318 no →
- afternoon round · Jun 22 · 798 articles · 521 yes / 405 no →
- morning round · Jun 22 · 574 articles · 491 yes / 315 no →
- afternoon round · Jun 19 · 240 articles · 75 yes / 121 no →
- morning round · Jun 19 · 613 articles · 418 yes / 349 no →
- afternoon round · Jun 18 · 772 articles · 569 yes / 389 no →
- morning round · Jun 18 · 639 articles · 499 yes / 342 no →
- afternoon round · Jun 17 · 683 articles · 567 yes / 257 no →
- morning round · Jun 17 · 722 articles · 489 yes / 409 no →
- afternoon round · Jun 16 · 726 articles · 580 yes / 325 no →
- morning round · Jun 16 · 699 articles · 485 yes / 371 no →
- afternoon round · Jun 15 · 747 articles · 632 yes / 342 no →
- morning round · Jun 15 · 499 articles · 508 yes / 239 no →
- the full run ledger →
447 articles537 stock×article rows
488 judged
210 with a YES142 with a NO
323 unknown verdicts
12 disagreements
fired 8:00 AM ET (on time)
Signals
Articles where at least one model said YES or NO on a headline it judged relevant — disagreements first, marked with a blue edge.
| stock | gpt-4.1-nano | gpt-4o-mini | panel | |
|---|---|---|---|---|
Cantor Fitzgerald Maintains Overweight on Uber Technologies, Lowers Price Target to $90 | ||||
| UBER | yes | no | 1 yes · 1 no | |
Sempra Raises FY2026 GAAP EPS Guidance from $4.87-$5.37 to $5.02-$5.55 vs $5.68 Est | ||||
| SRE | no | yes | 1 no · 1 yes | |
Sempra Q2 Adj. EPS $1.16 Beats $1.06 Estimate, Sales $2.997B Miss $3.188B Estimate | ||||
| SRE | no | yes | 1 no · 1 yes | |
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc. | ||||
| ARGX | unknown | yes | 1 unknown · 1 yes | |
| FBRX | no | yes | 1 no · 1 yes | |
Generate Biomedicines Q2 EPS $(0.52) Beats $(0.57) Estimate, Sales $6.314M Miss $6.625M Estimate | ||||
| GENB | no | yes | 1 no · 1 yes | |
Needham Maintains Buy on Joby Aviation, Lowers Price Target to $15 | ||||
| JOBY | yes | no | 1 yes · 1 no | |
Opus Genetics Q2 EPS $(0.14) Beats $(0.16) Estimate, Sales $755.000K Miss $2.470M Estimate | ||||
| IRD | no | yes | 1 no · 1 yes | |
Nuveen Churchill Direct Q2 EPS $0.41 Beats $0.39 Estimate, Sales $44.330M Miss $46.582M Estimate | ||||
| NCDL | no | yes | 1 no · 1 yes | |
Tecnoglass Narrows FY2026 Sales Guidance from $1.060B-$1.130B to $1.080B-$1.120B vs $1.097B Est | ||||
| TGLS | yes | no | 1 yes · 1 no | |
CORRECTION: Cogent Comms Hldgs Q2 EPS $1.38 Beats $(0.94) Estimate, Sales $235.559M Miss $239.637M Estimate | ||||
| CCOI | no | yes | 1 no · 1 yes | |
Commerce.com Q2 Adj. EPS $0.08 Beats $0.04 Estimate, Sales $84.511M Miss $85.441M Estimate | ||||
| CMRC | no | yes | 1 no · 1 yes | |
AI Trailblazers Nvidia, Palantir, Alphabet, and Meta Are Shaking Wall Street to Its Core With This $3.4 Billion Warning | ||||
| GOOG | no | no | 2/2 no | |
| GOOGL | yes | no | 1 yes · 1 no | |
| META | yes | no | 1 yes · 1 no | |
| NVDA | no | no | 2/2 no | |
| PLTR | no | no | 2/2 no | |
Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement | ||||
| ZYBT | yes | yes | 2/2 yes | |
Goldman Sachs Maintains Buy on Chime Financial, Raises Price Target to $33 | ||||
| CHYM | yes | yes | 2/2 yes | |
Sempra Sees FY2027 Adj EPS $5.10-$5.70 vs $5.52 Est | ||||
| SRE | yes | yes | 2/2 yes | |
argenx Commences $77/Shr Cash Tender Offer Through Subsidiary Avena Merger Sub To Acquire All Outstanding Shares Of Forte Biosciences | ||||
| ARGX | unknown | yes | 1 unknown · 1 yes | |
| FBRX | yes | yes | 2/2 yes | |
Cantor Fitzgerald Maintains Neutral on Expedia Group, Raises Price Target to $310 | ||||
| EXPE | yes | yes | 2/2 yes | |
Rosenblatt Maintains Buy on Miami International Hldgs, Raises Price Target to $62 | ||||
| MIAX | yes | yes | 2/2 yes | |
Goldman Sachs Maintains Neutral on ZipRecruiter, Raises Price Target to $5 | ||||
| ZIP | yes | yes | 2/2 yes | |
Sempra Affirms FY2026 Adj EPS Guidance of $4.80-$5.30 vs $5.11 Est | ||||
| SRE | unknown | yes | 1 unknown · 1 yes | |
Compass Therapeutics Q2 EPS $(0.13) Misses $(0.11) Estimate | ||||
| CMPX | no | no | 2/2 no | |
Cantor Fitzgerald Maintains Neutral on Shopify, Raises Price Target to $145 | ||||
| SHOP | unknown | yes | 1 unknown · 1 yes | |
Goldman Sachs Maintains Neutral on Bumble, Lowers Price Target to $3.5 | ||||
| BMBL | no | no | 2/2 no | |
Coincheck Group Q1 Sales $703.000M Beat $699.957M Estimate | ||||
| CNCK | yes | yes | 2/2 yes | |
Ingles Markets Q3 EPS $1.36 Down From $1.38 YoY, Sales $1.368B Up From $1.346B YoY | ||||
| IMKTA | no | no | 2/2 no | |
Priority Tech Holdings Q2 Adj. EPS $0.29 Beats $0.26 Estimate, Sales $262.300M Beat $257.815M Estimate | ||||
| PRTH | yes | yes | 2/2 yes | |
Cantor Fitzgerald Reiterates Overweight on IonQ, Maintains $70 Price Target | ||||
| IONQ | yes | yes | 2/2 yes | |
Sunstone Hotel Invts Q2 FFO $0.32 Beats $0.29 Estimate, Sales $277.100M Beat $268.283M Estimate | ||||
| SHO | yes | yes | 2/2 yes | |
Rosenblatt Maintains Buy on Advanced Micro Devices, Raises Price Target to $700 | ||||
| AMD | yes | yes | 2/2 yes | |
Novavax Q2 EPS $(0.32) Beats $(0.37) Estimate, Sales $56.698M Beat $52.513M Estimate | ||||
| NVAX | yes | yes | 2/2 yes | |
Needham Reiterates Buy on Uber Technologies, Maintains $109 Price Target | ||||
| UBER | yes | yes | 2/2 yes | |
Genie Energy Q2 EPS $0.43 Beats $0.25 Estimate, Sales $100.400M Miss $104.570M Estimate | ||||
| GNE | yes | yes | 2/2 yes | |
MercadoLibre's AI, Fintech And Commerce Boom Can't Offset Margin Concerns | ||||
| MELI | no | no | 2/2 no | |
Viridian Therapeutics Q2 EPS $(1.05) Misses $(1.02) Estimate, Sales $233.000K Beat $22.308K Estimate | ||||
| VRDN | no | no | 2/2 no | |
Palladyne AI Demonstrates Its SwarmOS Platform And Gremlin-X Unmanned, Reusable Mini-Bomber At The U.S. Army's Project Convergence Capstone 6 | ||||
| PDYN | unknown | yes | 1 unknown · 1 yes | |
Lexicon Pharmaceuticals Q2 EPS $(0.07) Misses $(0.05) Estimate, Sales $692.000K Miss $3.998M Estimate | ||||
| LXRX | no | no | 2/2 no | |
Tesla's Battery Business Is Growing Faster Than Its Cars— and a New Texas Factory for Megapack 3 Just Went Live | ||||
| TSLA | yes | yes | 2/2 yes | |
ITT Raises FY2026 GAAP EPS Guidance from $4.15-$4.45 to $4.47-$4.67 vs $5.11 Est | ||||
| ITT | no | no | 2/2 no | |
ITT Raises FY2026 Adj EPS Guidance from $7.70-$8.00 to $8.12-$8.32 vs $7.91 Est | ||||
| ITT | yes | yes | 2/2 yes | |
ITT Q2 Adj. EPS $2.08 Beats $1.95 Estimate, Sales $1.473B Beat $1.389B Estimate | ||||
| ITT | yes | yes | 2/2 yes | |
Avalo Therapeutics Q2 EPS $(0.83) Misses $(0.58) Estimate | ||||
| AVTX | no | no | 2/2 no | |
Paramount Skydance Acquisition Of Warner Bros. Discovery Receives UK CMA Approval | ||||
| PSKY | unknown | yes | 1 unknown · 1 yes | |
| WBD | unknown | no | 1 unknown · 1 no | |
Magnite Analysts Boost Their Forecasts Following Better-Than-Expected Q2 Earnings | ||||
| MGNI | yes | yes | 2/2 yes | |
BTIG Maintains Buy on HubSpot, Lowers Price Target to $250 | ||||
| HUBS | unknown | no | 1 unknown · 1 no | |
Cullinan Therapeutics Q2 EPS $(0.81) Beats $(0.85) Estimate | ||||
| CGEM | yes | yes | 2/2 yes | |
Goldman Sachs Maintains Neutral on Ramaco Resources, Lowers Price Target to $11 | ||||
| METC | unknown | no | 1 unknown · 1 no | |
SpaceX Bulls Pile Into $111 Calls Ahead of 911 Million-Share Unlock: Here's What to Know | ||||
| SPCX | yes | yes | 2/2 yes | |
Monte Rosa Therapeutics Q2 EPS $(0.43) Misses $(0.38) Estimate, Sales $8.968M Beat $5.524M Estimate | ||||
| GLUE | no | no | 2/2 no | |
Sabre Q2 Adj. EPS $(0.17) Misses $(0.04) Estimate, Sales $711.961M Beat $697.397M Estimate | ||||
| SABR | no | no | 2/2 no | |
Goldman Sachs Maintains Neutral on AppLovin, Lowers Price Target to $465 | ||||
| APP | unknown | no | 1 unknown · 1 no | |
This HubSpot Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday | ||||
| FRPT | no | no | 2/2 no | |
| HUBS | no | no | 2/2 no | |
| PODD | no | no | 2/2 no | |
| REXR | no | no | 2/2 no | |
| WTTR | no | no | 2/2 no | |
Foghorn Therapeutics Q2 EPS $(0.10) Beats $(0.23) Estimate, Sales $16.072M Beat $5.995M Estimate | ||||
| FHTX | yes | yes | 2/2 yes | |
Kelly Services Sees Q3 Sales $916.300M-$935.000M vs $929.333M Est | ||||
| KELYA | unknown | yes | 1 unknown · 1 yes | |
These Analysts Increase Their Forecasts On Block After Strong Q2 Results | ||||
| XYZ | yes | yes | 2/2 yes | |
SpaceX Stock Primed for Massive 122% Upside, JPMorgan Says | ||||
| SPCX | yes | yes | 2/2 yes | |
Sionna Therapeutics Q2 EPS $(0.66) Misses $(0.65) Estimate | ||||
| SION | no | no | 2/2 no | |
Open Text Sees Q1 Sales $1.220B-$1.250B vs $1.274B Est | ||||
| OTEX | no | no | 2/2 no | |
Open Text Sees FY2027 Sales $5.135B-$5.185B vs $5.228B Est | ||||
| OTEX | no | no | 2/2 no | |
Rosenblatt Maintains Buy on Magnite, Raises Price Target to $40 | ||||
| MGNI | yes | yes | 2/2 yes | |
FrontView REIT Raises FY2026 FFO Guidance from $1.29-$1.33 to $1.32-$1.34 vs $1.14 Est | ||||
| FVR | yes | yes | 2/2 yes | |
PepGen Receives Recommendation To Advance its Phase 2 FREEDOM2-DM1 Study Of PGN-EDODM1 In Participants With Myotonic Dystrophy Type 1 Into The Highest Dose Cohort | ||||
| PEPG | yes | yes | 2/2 yes | |
Kelly Services Sees Q3 Sales $916.300M-$935.000M vs $939.300M Est | ||||
| KELYA | no | no | 2/2 no | |
| KELYB | no | no | 2/2 no | |
ATI Raises FY2026 Adj EPS Guidance from $4.20-$4.48 to $4.90-$5.18 vs $4.48 Est | ||||
| ATI | yes | yes | 2/2 yes | |
SAB Biotherapeutics Q2 2026, Cash Balance Of $208.0M, Providing Runway Through 2028 | ||||
| SABS | yes | yes | 2/2 yes | |
Rosenblatt Maintains Buy on Dynatrace, Raises Price Target to $62 | ||||
| DT | yes | yes | 2/2 yes | |
Needham Maintains Buy on Extreme Networks, Lowers Price Target to $35 | ||||
| EXTR | unknown | yes | 1 unknown · 1 yes | |
ATI Q2 Adj. EPS $1.23 Beats $1.04 Estimate, Sales $1.261B Beat $1.218B Estimate | ||||
| ATI | yes | yes | 2/2 yes | |
Nayax Announces Application To Establish Connecticut-Chartered Non-Depository Innovation Bank; Launches Yellow Account Deposit Service With Adyen As Sponsoring Bank | ||||
| NYAX | unknown | yes | 1 unknown · 1 yes | |
Cars.com Sees Q3 Sales $183.903M-$187.581M vs $183.186M Est | ||||
| CARS | yes | yes | 2/2 yes | |
Orion Digital Corp. - Common Shares Q2 Adj. EPS $0.03 Beats $0.01 Estimate, Sales $12.175M Miss $12.650M Estimate | ||||
| ORIO | yes | yes | 2/2 yes | |
Goldman Sachs Maintains Neutral on Global Payments, Raises Price Target to $94 | ||||
| GPN | yes | yes | 2/2 yes | |
Meta Platforms Saw Free Cash Flow Plunge 91% to Just $784 Million as Artificial Intelligence (AI) Spending Ballooned. Here's Why That Should Worry Investors. | ||||
| AMZN | no | no | 2/2 no | |
| GOOG | no | no | 2/2 no | |
| GOOGL | no | no | 2/2 no | |
| META | no | no | 2/2 no | |
Cars.com Q2 Adj. EPS $0.51 Beats $0.27 Estimate, Sales $179.934M Miss $180.538M Estimate | ||||
| CARS | yes | yes | 2/2 yes | |
Cars.com Raises FY2026 Sales Guidance from $723.239M-$737.703M to $723.239M-$737.704M vs $729.429M Est | ||||
| CARS | unknown | yes | 1 unknown · 1 yes | |
Agenus Announces Registrational Phase 3 ROBBIN Trial Of Neoadjuvant BOT+BAL In High-Risk MSS Colon Cancer, With Initiation And First Patient Dosing Expected In Q1 2027 | ||||
| AGEN | unknown | yes | 1 unknown · 1 yes | |
Priority Tech Holdings Affirms FY2026 Sales Guidance of $1.010B-$1.040B vs $1.030B Est | ||||
| PRTH | yes | yes | 2/2 yes | |
AppLovin Analysts Cut Their Forecasts Following Q2 Earnings | ||||
| APP | no | no | 2/2 no | |
Gene Munster Predicts SpaceX Could Generate $135 Billion In Annual Revenue— Well Above Wall Street's Forecast: 'The Dust Is Settling...' | ||||
| GOOG | no | no | 2/2 no | |
| GOOGL | no | unknown | 1 no · 1 unknown | |
| SPCX | yes | yes | 2/2 yes | |
MACOM Technology Solns Sees Q4 Adj EPS $1.97-$2.03 vs $1.57 Est; Sees Sales $415.000M-$425.000M vs $368.734M Est | ||||
| MTSI | yes | yes | 2/2 yes | |
Needham Maintains Buy on Viavi Solutions, Lowers Price Target to $60 | ||||
| VIAV | unknown | yes | 1 unknown · 1 yes | |
BioVie Says Phase 2 SUNRISE-PD Trial Of Bezisterim In Early Parkinson's Disease Met Prespecified Endpoints, Showing Statistically Significant Motor And Non-Motor Improvements vs. Placebo | ||||
| BIVI | yes | yes | 2/2 yes | |
Rosenblatt Maintains Buy on Western Digital, Lowers Price Target to $800 | ||||
| WDC | unknown | yes | 1 unknown · 1 yes | |
InflaRx Q2 EPS $(0.10) Misses $(0.08) Estimate | ||||
| IFRX | no | no | 2/2 no | |
Climb Bio Q2 EPS $(0.18) Beats $(0.21) Estimate | ||||
| CLYM | yes | yes | 2/2 yes | |
Payoneer Global Q2 EPS $(0.01) Misses $0.06 Estimate, Sales $274.258M Beat $270.981M Estimate | ||||
| PAYO | no | no | 2/2 no | |
Short Squeeze And Earnings: Why SoundHound AI Stock Spiked Thursday | ||||
| SOUN | yes | yes | 2/2 yes | |
Sunstone Hotel Invts Raises FY2026 FFO Guidance from $0.88-$0.96 to $0.93-$0.98 vs $0.93 Est | ||||
| SHO | yes | yes | 2/2 yes | |
Sunrise Realty Trust Q2 Adj. EPS $0.29 Beats $0.28 Estimate, Sales $5.818M Miss $8.787M Estimate | ||||
| SUNS | yes | yes | 2/2 yes | |
Nova Sees Q3 GAAP EPS $2.46-$2.61 vs $2.47 Est | ||||
| NVMI | yes | yes | 2/2 yes | |
Kelly Services Q2 Adj. EPS $0.37 Beats $0.24 Estimate, Sales $1.041B Beat $1.009B Estimate | ||||
| KELYA | yes | yes | 2/2 yes | |
| KELYB | yes | yes | 2/2 yes | |
Suburban Propane Partners Q3 EPS $(0.26) Misses $(0.17) Estimate, Sales $261.379M Beat $255.000M Estimate | ||||
| SPH | no | no | 2/2 no | |
Parker Hannifin Sees FY2027 GAAP EPS $30.00-$31.00 vs $30.33 Est | ||||
| PH | unknown | yes | 1 unknown · 1 yes | |
Nova Sees Q3 Adj EPS $2.70-$2.85 vs $2.70 Est; Sees Sales $277.000M-$287.000M vs $279.399M Est | ||||
| NVMI | yes | yes | 2/2 yes | |
Parker Hannifin Sees FY2027 Adj EPS $34.25-$35.25 vs $34.04 Est; Sees Sales $20.942B-$21.537B vs $22.734B Est | ||||
| PH | no | no | 2/2 no | |
NetScout Systems Affirms FY2027 GAAP EPS Guidance of $1.55-$1.70 vs $1.48 Est | ||||
| NTCT | yes | yes | 2/2 yes | |
Cronos Group Q2 EPS $0.09 Beats $0.01 Estimate, Sales $53.007M Beat $44.200M Estimate | ||||
| CRON | yes | yes | 2/2 yes | |
Needham Maintains Buy on Arcutis Biotherapeutics, Raises Price Target to $40 | ||||
| ARQT | yes | yes | 2/2 yes | |
NetScout Systems Affirms FY2027 Adj EPS Guidance of $2.65-$2.80 vs $2.72 Est; Affirms FY2027 Sales Guidance of $885.000M-$915.000M vs $902.430M Est | ||||
| NTCT | yes | yes | 2/2 yes | |
Nova Q2 Adj. EPS $2.51 Beats $2.41 Estimate, Sales $255.000M Beat $250.327M Estimate | ||||
| NVMI | yes | yes | 2/2 yes | |
Collegium Pharmaceutical Q2 Adj. EPS $1.92 Beats $1.72 Estimate, Sales $199.878M Miss $201.206M Estimate | ||||
| COLL | yes | yes | 2/2 yes | |
Agenus Q2 Sales $34.500M Beat $34.000M Estimate | ||||
| AGEN | yes | yes | 2/2 yes | |
FrontView REIT Q2 FFO $0.33 Beats $0.29 Estimate, Sales $18.005M Miss $18.421M Estimate | ||||
| FVR | yes | yes | 2/2 yes | |
NetScout Systems Q1 Adj. EPS $0.52 Beats $0.38 Estimate, Sales $210.423M Beat $196.169M Estimate | ||||
| NTCT | yes | yes | 2/2 yes | |
Distribution Solns Gr Q2 Adj. EPS $0.47 Beats $0.41 Estimate, Sales $557.734M Beat $520.400M Estimate | ||||
| DSGR | yes | yes | 2/2 yes | |
MACOM Technology Solns Q3 Adj. EPS $1.40 Beats $1.35 Estimate, Sales $342.237M Beat $335.389M Estimate | ||||
| MTSI | yes | yes | 2/2 yes | |
Installed Building Prods Q2 Adj. EPS $2.91 Beats $2.55 Estimate, Sales $777.800M Beat $743.358M Estimate | ||||
| IBP | yes | yes | 2/2 yes | |
Collegium Pharmaceutical Lowers FY2026 Sales Guidance from $865.000M-$895.000M to $825.000M-$855.000M vs $872.278M Est | ||||
| COLL | no | no | 2/2 no | |
Parker Hannifin Q4 Adj. EPS $9.27 Beats $8.27 Estimate, Sales $5.755B Beat $5.572B Estimate | ||||
| PH | yes | yes | 2/2 yes | |
Crypto Legislation Delay 'Disappointing,' but 'Doesn't Change the Direction of Travel' for Digital Assets, Says Analyst | ||||
| COIN | unknown | no | 1 unknown · 1 no | |
Vistance Networks Q2 Adj. EPS $0.12 Misses $0.28 Estimate, Sales $319.600M Miss $495.500M Estimate | ||||
| VISN | no | no | 2/2 no | |
Goldman Sachs Maintains Buy on Shopify, Raises Price Target to $194 | ||||
| SHOP | yes | yes | 2/2 yes | |
Ken Griffin's Feud With Mamdani Hasn't Stopped His $6 Billion Manhattan Skyscraper— It's Now Under Demolition | ||||
| VNO | no | no | 2/2 no | |
These Analysts Slash Their Forecasts On Insulet After Q2 Results | ||||
| PODD | no | no | 2/2 no | |
Korro Bio Q2 EPS $(1.07) Beats $(1.31) Estimate | ||||
| KRRO | yes | yes | 2/2 yes | |
Needham Maintains Buy on AppLovin, Lowers Price Target to $500 | ||||
| APP | unknown | yes | 1 unknown · 1 yes | |
Goldman Sachs Maintains Buy on Enliven Therapeutics, Raises Price Target to $80 | ||||
| ELVN | yes | yes | 2/2 yes | |
Vital Farms Terminates Stock Buyback Program | ||||
| VITL | no | no | 2/2 no | |
Wells Fargo Downgrades AppLovin to Equal-Weight, Lowers Price Target to $357 | ||||
| APP | no | no | 2/2 no | |
CORRECTION: NexPoint Real Estate Q2 EAD/Share $0.46 Beats $0.40 Estimate | ||||
| NREF | yes | yes | 2/2 yes | |
Cartesian Therapeutics Q2 EPS $0.46 Beats $(0.86) Estimate | ||||
| RNAC | yes | yes | 2/2 yes | |
Needham Maintains Buy on Pattern Group, Raises Price Target to $29 | ||||
| PTRN | yes | yes | 2/2 yes | |
Gilat Satellite Networks Demonstrates Breakthrough Patent-Pending AI-Based Interference Detection And Cancellation Technology For Satellite Communication Links | ||||
| GILT | yes | yes | 2/2 yes | |
Goldman Sachs Maintains Sell on Louisiana-Pacific, Raises Price Target to $74 | ||||
| LPX | no | no | 2/2 no | |
Needham Maintains Buy on eBay, Raises Price Target to $135 | ||||
| EBAY | yes | yes | 2/2 yes | |
Arbe Robotics Appoints Assaf Pereg As CFO, Effective August 30 | ||||
| ARBE | unknown | yes | 1 unknown · 1 yes | |
Tarsus Pharmaceuticals Announces Agreement To Acquire Alkeus For $450M Upfront In Cash And Stock, Up To $350M In Milestones, Adding Phase 3 Stargardt Disease Therapy | ||||
| TARS | yes | yes | 2/2 yes | |
Wells Fargo Downgrades Insulet to Equal-Weight, Lowers Price Target to $144 | ||||
| PODD | no | no | 2/2 no | |
Deep Fission Says US Department Of Energy Approves Nuclear Safety Design Agreement For Its Gravity Nuclear Reactor | ||||
| FISN | yes | yes | 2/2 yes | |
Harrow Announces Agreement To Acquire Dry Eye Nasal Spray TYRVAYA From Viatris For $30M Cash At Closing, Up To $70M In Sales Milestones | ||||
| HROW | yes | yes | 2/2 yes | |
Medtronic Announces Expanded CE Mark Indication For Its Affera Mapping And Ablation System With Sphere-9 Catheter To Treat Ventricular Arrhythmias, Including Ventricular Tachycardia And Premature Ventricular Complexes | ||||
| MDT | yes | yes | 2/2 yes | |
JULONG HOLDING LTD (NASDAQ:JLHL) Demonstrates High-Growth Leadership and Momentum | ||||
| JLHL | yes | yes | 2/2 yes | |
Roivant's Priovant Announces First Patients Enrolled In Global Phase 3 BEACON+ Study Of Brepocitinib In Cutaneous Sarcoidosis; Topline Data Expected In 2028 | ||||
| ROIV | unknown | yes | 1 unknown · 1 yes | |
Aya Gold & Silver Acquires Strategic Exploration Portfolio Comprising Three Mining Licenses And 18 Exploration Permits In Morocco For MAD10 Million | ||||
| AYA | yes | yes | 2/2 yes | |
Goldman Sachs Maintains Sell on SolarEdge Technologies, Lowers Price Target to $30 | ||||
| SEDG | no | no | 2/2 no | |
Zoetis Announces Appointment Of Jay Saccaro As CFO And COO Effective August 17 | ||||
| ZTS | unknown | yes | 1 unknown · 1 yes | |
Kodiak Sciences Announces Completion Of 300-Patient Enrollment In First Pivotal Cohort Of Phase 3 PEAK Trial For KSI-101; Says Topline Data On Track For December 2026 | ||||
| KOD | unknown | yes | 1 unknown · 1 yes | |
3 Reasons Alphabet Stock Has Investors Buzzing Right Now | ||||
| GOOG | unknown | yes | 1 unknown · 1 yes | |
| GOOGL | unknown | yes | 1 unknown · 1 yes | |
BIO-key International Announces Strategic Partnership With Maktabi Tech To Deploy PortalGuard IAM Platform Across Saudi Arabian Educational Institutions | ||||
| BKYI | yes | yes | 2/2 yes | |
GH Research Q2 EPS $(0.23) Beats $(0.30) Estimate | ||||
| GHRS | yes | yes | 2/2 yes | |
Safe Pro Group Announces $780K Purchase Order From New Department Of War Prime Contractor For AI Threat Detection Tech, Blue UAS Drones | ||||
| SPAI | yes | yes | 2/2 yes | |
ProFrac Holding Q2 Sales $498.100M Miss $498.760M Estimate | ||||
| ACDC | no | no | 2/2 no | |
Six Flags Entertainment Q2 Sales $864.919M Miss $933.338M Estimate | ||||
| FUN | no | no | 2/2 no | |
Needham Maintains Buy on Block, Raises Price Target to $100 | ||||
| XYZ | yes | yes | 2/2 yes | |
ConocoPhillips Appoints Andy O’Brien As CEO, Effective September 1; Ryan Lance To Become Executive Chair | ||||
| COP | unknown | yes | 1 unknown · 1 yes | |
Driven Brands Hldgs Q2 Adj. EPS $0.29 Beats $0.26 Estimate, Sales $507.416M Beat $506.309M Estimate | ||||
| DRVN | yes | yes | 2/2 yes | |
Tarsus Pharmaceuticals To Acquire Alkeus Pharmaceuticals, A Closely Held Biotech Firm Developing Gildeuretinol, An Investigational Once-Daily Oral Therapy For Stargardt Disease; Terms Not Disclosed | ||||
| TARS | unknown | yes | 1 unknown · 1 yes | |
Driven Brands Hldgs Affirms FY2026 Adj EPS Guidance of $1.15-$1.25 vs $1.22 Est; Affirms FY2026 Sales Guidance of $1.950B-$2.050B vs $1.999B Est | ||||
| DRVN | yes | yes | 2/2 yes | |
Is Microsoft Still Undervalued After Its 25% Post-Earnings Rally? | ||||
| AMZN | unknown | no | 1 unknown · 1 no | |
| GOOG | unknown | no | 1 unknown · 1 no | |
| GOOGL | unknown | no | 1 unknown · 1 no | |
| MSFT | yes | unknown | 1 yes · 1 unknown | |
Goldman Sachs Maintains Neutral on Capri Holdings, Lowers Price Target to $18 | ||||
| CPRI | unknown | no | 1 unknown · 1 no | |
Why Is Fluence Energy Stock Sinking Thursday? | ||||
| FLNC | unknown | no | 1 unknown · 1 no | |
TripAdvisor Q2 Adj. EPS $0.35 Misses $0.37 Estimate, Sales $441.900M Miss $503.851M Estimate | ||||
| TRIP | no | no | 2/2 no | |
Roivant Sciences Q1 Adj. EPS $(0.34) Misses $(0.32) Estimate, Sales $1.442M Miss $2.057M Estimate | ||||
| ROIV | no | no | 2/2 no | |
WPP H1 EPS $0.02 Down From $0.27 YoY, Sales $8.570B Beat $3.260B Estimate | ||||
| WPP | no | no | 2/2 no | |
HC Wainwright & Co. Initiates Coverage On Atrium Therapeutics with Buy Rating, Announces Price Target of $25 | ||||
| RNA | yes | yes | 2/2 yes | |
Versant Media Group Q2 EPS $1.49 Beats $1.34 Estimate, Sales $1.640B Beat $1.618B Estimate | ||||
| VSNT | yes | yes | 2/2 yes | |
B of A Securities Maintains Buy on AppLovin, Lowers Price Target to $430 | ||||
| APP | yes | yes | 2/2 yes | |
Xeris Biopharma Holdings Q2 EPS $(0.18) Misses $0.00 Estimate, Sales $92.100M Beat $90.225M Estimate | ||||
| XERS | no | no | 2/2 no | |
Iovance Biotherapeutics Affirms FY2026 Sales Guidance of $350.000M-$370.000M vs $362.083M Est | ||||
| IOVA | yes | yes | 2/2 yes | |
BKV Q2 Adj. EPS $0.46 Beats $0.28 Estimate, Sales $465.535M Beat $358.865M Estimate | ||||
| BKV | yes | yes | 2/2 yes | |
Open Text Q4 Adj. EPS $1.23 Beats $1.05 Estimate, Sales $1.349B Beat $1.316B Estimate | ||||
| OTEX | yes | yes | 2/2 yes | |
Insmed Q2 EPS $(0.06) Beats $(0.73) Estimate, Sales $425.486M Beat $392.836M Estimate | ||||
| INSM | yes | yes | 2/2 yes | |
BlackSky Technology Q2 EPS $(0.54) Misses $(0.36) Estimate, Sales $33.316M Beat $30.680M Estimate | ||||
| BKSY | no | no | 2/2 no | |
Ironwood Pharmaceuticals Raises FY2026 Sales Guidance from $450.000M-$475.000M to $460.000M-$485.000M vs $460.118M Est | ||||
| IRWD | yes | yes | 2/2 yes | |
Warner Bros. Discovery Q2 EPS $0.06 Beats $(0.13) Estimate, Sales $8.717B Miss $9.290B Estimate | ||||
| WBD | yes | yes | 2/2 yes | |
Ironwood Pharmaceuticals Q2 Adj. EPS $0.31 Misses $0.36 Estimate, Sales $113.041M Miss $114.844M Estimate | ||||
| IRWD | no | no | 2/2 no | |
Top Wall Street Forecasters Revamp Airbnb Expectations Ahead Of Q2 Earnings | ||||
| ABNB | unknown | yes | 1 unknown · 1 yes | |
Arbe Robotics Q2 Adj. EPS $(0.06) Beats $(0.07) Estimate, Sales $703.000K Beat $500.000K Estimate | ||||
| ARBE | yes | yes | 2/2 yes | |
Bentley Systems Q2 Adj. EPS $0.35 Beats $0.32 Estimate, Sales $410.700M Miss $412.221M Estimate | ||||
| BSY | yes | yes | 2/2 yes | |
Nexstar Media Gr Q2 Adj. EPS $3.61 May Not Compare To $6.42 Estimate, Sales $1.993B Beat $1.971B Estimate | ||||
| NXST | no | no | 2/2 no | |
Resolute Holdings Mgmt Q2 Adj. EPS $0.69 Up From $(0.07) YoY, Sales $473.200M Up From $119.592M YoY | ||||
| RHLD | yes | yes | 2/2 yes | |
Peloton Interactive Sees FY2027 Sales $2.300B-$2.400B vs $2.417B Est | ||||
| PTON | no | no | 2/2 no | |
Fiserv Q2 Adj. EPS $1.84 Misses $1.91 Estimate, Sales $5.292B Beat $5.039B Estimate | ||||
| FISV | no | no | 2/2 no | |
Peloton Interactive Sees Q1 Sales $545.000M-$565.000M vs $562.569M Est | ||||
| PTON | unknown | yes | 1 unknown · 1 yes | |
Frontdoor Q2 Adj. EPS $1.93 Beats $1.76 Estimate, Sales $645.000M Beat $643.638M Estimate | ||||
| FTDR | yes | yes | 2/2 yes | |
Appian Q2 Adj. EPS $0.13 Beats $0.00 Estimate, Sales $203.256M Beat $193.498M Estimate | ||||
| APPN | yes | yes | 2/2 yes | |
ConocoPhillips Q2 Adj. EPS $3.24 Beats $2.88 Estimate, Sales $19.522B Beat $18.796B Estimate | ||||
| COP | yes | yes | 2/2 yes | |
Sotera Health Q2 Adj. EPS $0.26 Beats $0.24 Estimate, Sales $321.375M Beat $309.391M Estimate | ||||
| SHC | yes | yes | 2/2 yes | |
Optimum Communications Q2 EPS $(0.67) Misses $(0.17) Estimate, Sales $2.020B Miss $2.042B Estimate | ||||
| OPTU | no | no | 2/2 no | |
BTIG Maintains Buy on Paycom Software, Raises Price Target to $230 | ||||
| PAYC | yes | yes | 2/2 yes | |
Insmed Raises FY2026 Sales Guidance from $1.450B-$1.470B to $1.700B-$1.870B vs $1.705B Est | ||||
| INSM | yes | yes | 2/2 yes | |
Appian Raises FY2026 Adj EPS Guidance from $0.94-$1.05 to $1.04-$1.12 vs $0.99 Est; Raises FY2026 Sales Guidance from $819.000M-$831.000M to $845.000M-$853.000M vs $826.290M Est | ||||
| APPN | yes | yes | 2/2 yes | |
Viatris Q2 Adj. EPS $0.69 Beats $0.60 Estimate, Sales $3.756B Beat $3.675B Estimate | ||||
| VTRS | yes | yes | 2/2 yes | |
Genius Sports Raises FY2026 Sales Guidance from $990.000M-$1.010B to $1.005B-$1.025B vs $1.004B Est | ||||
| GENI | yes | yes | 2/2 yes | |
Commerce.com Lowers FY2026 Sales Guidance from $347.500M-$369.500M to $336.500M-$344.500M vs $355.154M Est | ||||
| CMRC | no | no | 2/2 no | |
Commerce.com Sees Q3 Sales $82.500M-$85.500M vs $89.093M Est | ||||
| CMRC | no | no | 2/2 no | |
Appian Sees Q3 Adj EPS $0.31-$0.35 vs $0.32 Est; Sees Sales $214.000M-$218.000M vs $207.936M Est | ||||
| APPN | yes | yes | 2/2 yes | |
Lifetime Brands Q2 Adj. EPS $1.18 Beats $(0.21) Estimate, Sales $141.569M Beat $136.658M Estimate | ||||
| LCUT | yes | yes | 2/2 yes | |
D-Wave Quantum Q2 EPS $(0.13) Misses $(0.10) Estimate, Sales $3.076M Miss $4.025M Estimate | ||||
| QBTS | no | no | 2/2 no | |
Regenxbio Q2 EPS $0.43 Beats $(0.03) Estimate, Sales $108.019M Miss $117.127M Estimate | ||||
| RGNX | yes | yes | 2/2 yes | |
Intellia Therapeutics Q2 EPS $(0.80) Misses $(0.79) Estimate, Sales $7.659M Miss $13.904M Estimate | ||||
| NTLA | no | no | 2/2 no | |
Lee Enterprises Q3 EPS $0.21 Beats $(0.16) Estimate, Sales $125.970M Down From $141.294M YoY | ||||
| LEE | yes | yes | 2/2 yes | |
RAmylyx Pharma Q2 EPS $(0.39) Misses $(0.36) Estimate, Cash & Equivalents $279.8M. Cash runway Expected To Fund Operations Till 2028 | ||||
| AMLX | no | no | 2/2 no | |
Gogo Lowers FY2026 Sales Guidance from $905.000M-$945.000M to $870.000M-$895.000M vs $914.635M Est | ||||
| GOGO | no | no | 2/2 no | |
Evolent Health Raises FY2026 Sales Guidance from $2.400B-$2.600B to $2.600B-$2.700B vs $2.503B Est | ||||
| EVH | yes | yes | 2/2 yes | |
CareCloud Affirms FY2026 GAAP EPS Guidance of $0.20-$0.23 vs $0.21 Est; Affirms FY2026 Sales Guidance of $128.000M-$132.000M vs $131.245M Est | ||||
| CCLD | yes | yes | 2/2 yes | |
Axcelis Technologies Sees Q3 GAAP EPS $0.76 vs $0.73 Est | ||||
| ACLS | yes | yes | 2/2 yes | |
Axcelis Technologies Sees Q3 Adj EPS $1.11 vs $1.04 Est; Sees Sales $230.000M vs $214.846M Est | ||||
| ACLS | yes | yes | 2/2 yes | |
HC Wainwright & Co. Initiates Coverage On Immuneering with Buy Rating, Announces Price Target of $14 | ||||
| IMRX | yes | yes | 2/2 yes | |
Shift4 Payments Q2 Adj. EPS $1.32 Beats $1.25 Estimate, Sales $1.295B Beat $1.239B Estimate | ||||
| FOUR | yes | yes | 2/2 yes | |
Unity Software Q2 Adj. EPS $0.28 Beats $(0.09) Estimate, Sales $546.468M Beat $514.613M Estimate | ||||
| U | yes | yes | 2/2 yes | |
Ligand Pharmaceuticals Raises FY2026 Adj EPS Guidance from $8.50-$9.50 to $9.00-$9.50 vs $9.16 Est; Affirms FY2026 Sales Guidance of $270.000M-$310.000M vs $288.559M Est | ||||
| LGND | yes | yes | 2/2 yes | |
Precision BioSciences Q2 EPS $(1.26) Misses $(0.81) Estimate | ||||
| DTIL | no | no | 2/2 no | |
Vital Farms Affirms FY2026 Sales Guidance of $775.000M-$800.000M vs $774.170M Est | ||||
| VITL | yes | yes | 2/2 yes | |
Arbe Robotics Affirms FY2026 Sales Guidance of $4.000M-$6.000M vs $4.500M Est | ||||
| ARBE | unknown | yes | 1 unknown · 1 yes | |
Immunocore Hldgs Q2 EPS $(0.02) Misses $0.02 Estimate, Sales $115.927M Beat $110.374M Estimate | ||||
| IMCR | no | no | 2/2 no | |
Iovance Biotherapeutics Q2 EPS $(0.11) Beats $(0.14) Estimate, Sales $99.313M Beat $87.832M Estimate | ||||
| IOVA | yes | yes | 2/2 yes | |
Evolent Health Q2 Adj. EPS $0.02 Beats $(0.02) Estimate, Sales $652.520M Beat $597.997M Estimate | ||||
| EVH | yes | yes | 2/2 yes | |
Smith Douglas Homes Q2 EPS $0.03 Misses $0.11 Estimate, Sales $273.026M Beat $256.220M Estimate | ||||
| SDHC | no | no | 2/2 no | |
Lantheus Holdings Q2 Adj. EPS $1.55 Beats $1.30 Estimate, Sales $388.200M Beat $362.416M Estimate | ||||
| LNTH | yes | yes | 2/2 yes | |
BlackSky Technology Affirms FY2026 Sales Guidance of $130.000M-$150.000M vs $136.960M Est | ||||
| BKSY | yes | yes | 2/2 yes | |
Frontdoor Sees Q3 Sales $642.000M-$652.000M vs $642.324M Est | ||||
| FTDR | unknown | yes | 1 unknown · 1 yes | |
GPGI Q2 Adj. EPS $0.17 Beats $0.14 Estimate, Sales $473.200M Beat $466.928M Estimate | ||||
| GPGI | yes | yes | 2/2 yes | |
Scholar Rock Holding Q2 EPS $(0.84) Beats $(0.85) Estimate; Cash Balance Of $492M | ||||
| SRRK | yes | yes | 2/2 yes | |
Shift4 Payments Lowers FY2026 Adj EPS Guidance from $5.50-$5.70 to $5.15-$5.35 vs $5.56 Est | ||||
| FOUR | no | no | 2/2 no | |
KVH Industries Q2 EPS $0.01 Misses $0.04 Estimate, Sales $33.723M Beat $33.700M Estimate | ||||
| KVHI | no | no | 2/2 no | |
Frontdoor Raises FY2026 Sales Guidance from $2.155B-$2.195B to $2.190B-$2.210B vs $2.184B Est | ||||
| FTDR | yes | yes | 2/2 yes | |
GPGI Affirms FY2026 Sales Guidance of $1.950B-$2.100B vs $1.964B Est | ||||
| GPGI | yes | yes | 2/2 yes | |
CareCloud Q2 Adj. EPS $0.06, Inline, Sales $31.880M Beat $31.851M Estimate | ||||
| CCLD | yes | yes | 2/2 yes | |
Tecnoglass Q2 Adj. EPS $0.54 Beats $0.52 Estimate, Sales $295.291M Beat $265.300M Estimate | ||||
| TGLS | yes | yes | 2/2 yes | |
Genius Sports Q2 EPS $(0.28) Misses $(0.07) Estimate, Sales $195.503M Beat $184.442M Estimate | ||||
| GENI | no | no | 2/2 no | |
MidCap Financial Q1 EPS $0.40 Beats $0.36 Estimate, Sales $68.226M Miss $68.392M Estimate | ||||
| MFIC | yes | yes | 2/2 yes | |
Keurig Dr Pepper Affirms FY2026 Sales Guidance of $25.900B-$26.400B vs $26.267B Est | ||||
| KDP | unknown | yes | 1 unknown · 1 yes | |
Dana Q2 Adj. EPS $0.19 Misses $0.69 Estimate, Sales $2.010B Beat $1.938B Estimate | ||||
| DAN | no | no | 2/2 no | |
Gogo Q2 EPS $(0.01) Misses $0.06 Estimate, Sales $222.800M Miss $229.350M Estimate | ||||
| GOGO | no | no | 2/2 no | |
HC Wainwright & Co. Maintains Buy on Mirum Pharmaceuticals, Lowers Price Target to $140 | ||||
| MIRM | yes | yes | 2/2 yes | |
TIC Solutions Sees FY2027 Sales $2.150B-$2.250B vs $2.293B Est | ||||
| TIC | no | no | 2/2 no | |
Axcelis Technologies Q2 Adj. EPS $1.06 Beats $0.89 Estimate, Sales $215.175M Beat $204.985M Estimate | ||||
| ACLS | yes | yes | 2/2 yes | |
Cogent Comms Hldgs Q2 EPS $(1.09) Misses $(0.94) Estimate, Sales $235.559M Miss $239.637M Estimate | ||||
| CCOI | no | no | 2/2 no | |
Fiserv Lowers FY2026 Adj EPS Guidance from $8.00-$8.30 to $7.20-$7.40 vs $8.10 Est | ||||
| FISV | no | no | 2/2 no | |
Via Transportation Raises FY2026 Sales Guidance from $547.000M-$550.000M to $550.000M-$553.000M vs $548.768M Est | ||||
| VIA | yes | yes | 2/2 yes | |
Marriott Vacations Q2 Adj. EPS $2.31 Beats $1.97 Estimate, Sales $1.320B Beat $1.290B Estimate | ||||
| VAC | yes | yes | 2/2 yes | |
Vital Farms Q2 EPS $(0.72) Misses $(0.44) Estimate, Sales $166.029M Beat $160.234M Estimate | ||||
| VITL | no | no | 2/2 no | |
Sotera Health Raises FY2026 Adj EPS Guidance from $0.93-$1.01 to $0.95-$1.01 vs $0.97 Est; Raises FY2026 Sales Guidance from $1.233B-$1.251B to $1.236B-$1.254B vs $1.241B Est | ||||
| SHC | yes | yes | 2/2 yes | |
More Americans Have Access to Credit While Debt Growth Has Moderated | ||||
| TRU | yes | yes | 2/2 yes | |
Glycolic Acid Market Size to Skyrocket USD 818.89 Million by 2035, Growing at 8.06% CAGR | SNS Insider | ||||
| CC | unknown | yes | 1 unknown · 1 yes | |
| DD | unknown | unknown | 2/2 unknown | |
Brilliant Earth Reports Second Quarter Results and Raises Annual Profitability Guidance | ||||
| BRLT | yes | yes | 2/2 yes | |
Kinross upgraded to ‘BBB’ Rating by S&P Global Ratings | ||||
| KGC | yes | yes | 2/2 yes | |
Here's the Major Winner of Amazon's 2026 $220 Billion Capital Expenditure Bill | ||||
| AMZN | yes | unknown | 1 yes · 1 unknown | |
| MU | unknown | unknown | 2/2 unknown | |
Should USANA Health Sciences (USNA) Revisit Its Valuation After Lowered Guidance And Q2 Loss? | ||||
| USNA | no | no | 2/2 no | |
DP World Grows UK Logistics Operations With Transfer of Six UK Grocery Sites From GXO | ||||
| GXO | no | no | 2/2 no | |
Equifax Canada Survey Shows One in Four Canadians Expect to Make Only Minimum Credit Card Payments | ||||
| EFX | unknown | no | 1 unknown · 1 no | |
Does Limbach Holdings' (LMB) Raised Revenue Outlook Justify Its Aggressive Regional Acquisition Strategy? | ||||
| LMB | unknown | yes | 1 unknown · 1 yes | |
Donald Trump's 10% Global Tariff Expired on July 24. Its Section 301 Replacement Covers 60 Countries at Rates of 10% to 12.5%. | ||||
| NKE | unknown | unknown | 2/2 unknown | |
| NUE | unknown | no | 1 unknown · 1 no | |
Intel and ByteDance stakes help SoftBank beat expectations | ||||
| INTC | unknown | yes | 1 unknown · 1 yes | |
Micron Is an Incredible Bargain Below $1,000 | ||||
| AMZN | unknown | no | 1 unknown · 1 no | |
| MU | yes | unknown | 1 yes · 1 unknown | |
I've Been Wrong About Amazon Stock for Almost 10 Years. Here's Why I'm Finally Changing My Mind. | ||||
| AMZN | unknown | yes | 1 unknown · 1 yes | |
| GOOG | unknown | no | 1 unknown · 1 no | |
| GOOGL | unknown | no | 1 unknown · 1 no | |
| META | unknown | no | 1 unknown · 1 no | |
Amazon, Alphabet, and Microsoft All Delivered Soaring Cloud Growth Thanks to AI. Here's the 1 I'd Buy Right Now | ||||
| AMZN | yes | yes | 2/2 yes | |
| GOOG | yes | yes | 2/2 yes | |
| GOOGL | yes | yes | 2/2 yes | |
| MSFT | yes | yes | 2/2 yes | |
Micware Launches Security Solutions Powered by the “Wiz” Cloud and AI Security Platform | ||||
| MWC | yes | yes | 2/2 yes | |
ミックウェア、クラウド／AIセキュリティプラットフォーム「Wiz」を活用したセキュリティソリューションの提供を開始 | ||||
| MWC | yes | yes | 2/2 yes | |
GCL Announces Plan to Propose Adjournment of Extraordinary General Meeting to December 1, 2026 at Its August 7, 2026 Meeting | ||||
| GCL | unknown | no | 1 unknown · 1 no | |
red violet Announces Pricing of $100 Million Underwritten Public Offering of Common Stock | ||||
| RDVT | unknown | no | 1 unknown · 1 no | |
Why Did ZETA, APPS, BLMN Stocks Soar To 52-Week Highs Today? | ||||
| APPS | unknown | yes | 1 unknown · 1 yes | |
| BLMN | yes | yes | 2/2 yes | |
Hagens Berman Sobol Shapiro LLP Notifies Shareholders of Photronics, Inc. (PLAB) of a Securities Class Action Lawsuit and the Opportunity to Seek a Lead Plaintiff Position | ||||
| PLAB | unknown | no | 1 unknown · 1 no | |
DEADLINE NEXT WEEK: Hagens Berman Advises ADMA Biologics, Inc. Investors to Contact the Firm Before August 10, 2026 | ||||
| ADMA | unknown | no | 1 unknown · 1 no | |
Black Rock Coffee Bar, Inc. (BRCB) Faces Securities Class Action Related to IPO Disclosures Regarding Adverse Impact of Sales Transfer Phenomenon – Hagens Berman | ||||
| BRCB | no | no | 2/2 no | |
EMBC 12-DAY DEADLINE ALERT: Embecta Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Hagens Berman | ||||
| EMBC | unknown | no | 1 unknown · 1 no | |
Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline | ||||
| ERAS | unknown | no | 1 unknown · 1 no | |
| RVMD | no | no | 2/2 no | |
RBLX 2-DAY DEADLINE ALERT: Roblox Corporation (RBLX) Facing Securities Class Action Amid Surprise Age Verification Impact, Investors with Losses Encouraged to Contact Hagens Berman | ||||
| RBLX | no | no | 2/2 no | |
AGNC Investment Trades 28% Above Its $8.58 Book Value. What Has to Go Right to Justify It. | ||||
| AGNC | unknown | no | 1 unknown · 1 no | |
Why AMD Stock Dropped Today | ||||
| AMD | no | no | 2/2 no | |
| META | unknown | no | 1 unknown · 1 no | |
| MSFT | unknown | no | 1 unknown · 1 no | |
| NVDA | unknown | unknown | 2/2 unknown | |
| ORCL | unknown | no | 1 unknown · 1 no | |
HUBG INVESTOR ALERT: Hub Group (NASDAQ: HUBG) Investors Have Opportunity to Lead Shareholder Class Action | ||||
| HUBG | unknown | no | 1 unknown · 1 no | |
What Does Toast's Principal Accounting Officer Selling 35% of Her Directly-Held Company Shares Mean for Investors? | ||||
| TOST | unknown | no | 1 unknown · 1 no | |
Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit – Hagens Berman | ||||
| REGN | no | no | 2/2 no | |
PNR Alert: Pentair plc (NYSE: PNR) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, October 2, 2026 Lead Plaintiff Deadline | ||||
| PNR | no | no | 2/2 no | |
Snap (SNAP) Stock Could Be Undervalued Even After Recent Gains | ||||
| SNAP | yes | yes | 2/2 yes | |
Primoris Services Corporation Notice of September 21, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline | ||||
| PRIM | unknown | no | 1 unknown · 1 no | |
Athene Prices $1,000,000,000 Investment Grade Senior Notes Offering | ||||
| APO | yes | unknown | 1 yes · 1 unknown | |
DR. REDDY’S LABORATORIES INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud | ||||
| RDY | unknown | no | 1 unknown · 1 no | |
HIMS & HERS HEALTH, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud | ||||
| HIMS | no | no | 2/2 no | |
| META | no | no | 2/2 no | |
JEF SHAREHOLDER ALERT: Jefferies Financial Group, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations | ||||
| JEF | no | no | 2/2 no | |
MYRIAD GENETICS, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud | ||||
| MYGN | no | no | 2/2 no | |
FUTU DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Futu Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - FUTU | ||||
| FUTU | no | no | 2/2 no | |
Life360's Revenue Grew 38% While the Stock Fell. Here's What to Make of the Latest Director Sale | ||||
| LIF | unknown | no | 1 unknown · 1 no | |
Disney Reaffirms Double-Digit Earnings Growth, Targets $9 Billion in Buybacks. Here’s What Investors Need to Know. | ||||
| DIS | yes | yes | 2/2 yes | |
A Life360 Director Sold Stock at Exactly $60. Here's What Long-Term Investors Should Know | ||||
| LIF | unknown | no | 1 unknown · 1 no | |
A Life360 Founder Sold $1.7 Million in Stock. Here's What Long-Term Investors Should Know | ||||
| LIF | unknown | no | 1 unknown · 1 no | |
Cogent Communications Holdings Securities Fraud Class Action Result of Undisclosed Demand and Backlog Issues and approximately 29% Stock Decline - Investors may Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP | ||||
| CCOI | no | no | 2/2 no | |
Wix.com Ltd. Notice of September 22, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline | ||||
| CCOI | unknown | no | 1 unknown · 1 no | |
| WIX | unknown | no | 1 unknown · 1 no | |
Grab Holdings (GRAB) Raises 2026 Guidance, Is The Stock Still Below Fair Value? | ||||
| GRAB | yes | yes | 2/2 yes | |
Here's How to Read Super Group Insider Moves as Shares Slipped 6% After Earnings | ||||
| SGHC | unknown | no | 1 unknown · 1 no | |
Why Rivian Is Poised to Soar. Hint: It's Not All R2 Hype. | ||||
| LCID | no | no | 2/2 no | |
| RIVN | yes | yes | 2/2 yes | |
| UBER | no | no | 2/2 no | |
SmartRent Inc (SMRT) (Q2 2026) Earnings Call Highlights: Core Revenue Surges 14% as Adjusted ... | ||||
| SMRT | yes | yes | 2/2 yes | |
Usana Health Sciences Inc (USNA) (Q2 2026) Earnings Call Highlights: Strategic Pivots Amidst ... | ||||
| USNA | unknown | yes | 1 unknown · 1 yes | |
Here's How to Read Super Group Insider Sales After the Firm Beat and Raised Guidance | ||||
| SGHC | unknown | yes | 1 unknown · 1 yes | |
Hudson Technologies Re-Awarded Defense Logistics Agency Contract | ||||
| HDSN | yes | yes | 2/2 yes | |
Why Eli Lilly Stock Climbed Today | ||||
| ATAI | unknown | no | 1 unknown · 1 no | |
| LLY | yes | yes | 2/2 yes | |
Should You Forget Tesla Stock Near a 52-Week Low? | ||||
| TSLA | unknown | no | 1 unknown · 1 no | |
Grab Holdings (GRAB) Is Up 11.6% After Q2 Beat, Guidance Hike And Larger Buyback Authorization – Has The Bull Case Changed? | ||||
| GRAB | yes | yes | 2/2 yes | |
Grupo Aeroportuario Del Pacifico Reports A Passenger Traffic Increase In July 2026 Of 1.2% Compared To 2025 | ||||
| PAC | unknown | yes | 1 unknown · 1 yes | |
TBLA INVESTOR ALERT: Investigation of Taboola.com Ltd. Announced by Holzer & Holzer, LLC | ||||
| TBLA | unknown | no | 1 unknown · 1 no | |
UiPath (PATH) Registers a Bigger Fall Than the Market: Important Facts to Note | ||||
| PATH | no | no | 2/2 no | |
Why the Market Dipped But Nu Holdings Ltd. (NU) Gained Today | ||||
| NU | yes | yes | 2/2 yes | |
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of ARS Pharmaceuticals, Inc. Securities and Sets a Lead Plaintiff Deadline of October 5, 2026 | ||||
| SPRY | no | no | 2/2 no | |
Snap's $2,195 Glasses Will See 'Mass Market Adoption' By End of Decade, Says CEO Evan Spiegel: 'Designed For a Future in Which AI Does More Work' | ||||
| SNAP | yes | yes | 2/2 yes | |
3 Reasons Investors Should Ignore Cipher Digital's Double Miss | ||||
| AMZN | unknown | unknown | 2/2 unknown | |
| CIFR | no | no | 2/2 no | |
Aura Declares Dividend of US$0.72 Per Share and US$0.24 Per BDR Based on Q2 2026 Results, Resulting in a Dividend Yield of 4.3% in the LTM | ||||
| AUGO | yes | yes | 2/2 yes | |
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Pentair plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PNR | ||||
| ERAS | no | no | 2/2 no | |
| FSLR | no | no | 2/2 no | |
| PNR | no | no | 2/2 no | |
Albertsons CFO Sharon Mccollam Buys 9,000 Shares at $11.48. Is This a Bullish Signal for the Rest of 2026? | ||||
| ACI | yes | yes | 2/2 yes | |
| BBY | unknown | no | 1 unknown · 1 no | |
| WSM | unknown | no | 1 unknown · 1 no | |
Grab CFO makes AI reveal, sends market into frenzy | ||||
| GRAB | unknown | yes | 1 unknown · 1 yes | |
Why Gibraltar Industries Stock Soared by 14% on Wednesday | ||||
| ROCK | yes | yes | 2/2 yes | |
Stock Market Today, Aug. 5: Shopify Soars 17% After Beating Q2 Estimates, Raises Q3 Outlook | ||||
| EBAY | unknown | no | 1 unknown · 1 no | |
| ETSY | no | no | 2/2 no | |
| SHOP | yes | yes | 2/2 yes | |
Flotek Industries Inc (FTK) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic ... | ||||
| FTK | yes | yes | 2/2 yes | |
Orion Energy Systems Inc (OESX) (Q1 2027) Earnings Call Highlights: Revenue Surges 32% as Data ... | ||||
| OESX | yes | yes | 2/2 yes | |
Materion Corp (MTRN) (Q2 2026) Earnings Call Highlights: Record Sales and Raised Guidance ... | ||||
| MTRN | yes | yes | 2/2 yes | |
Limbach Holdings Inc (LMB) (Q2 2026) Earnings Call Highlights: Strong Bookings and Strategic ... | ||||
| LMB | yes | yes | 2/2 yes | |
BLAIZE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Blaize Holdings, Inc. and Encourages Investors to Contact the Firm | ||||
| BZAI | no | no | 2/2 no | |
Ethan Allen Confirms Receipt of Director Nominations from Doug Bergeron | ||||
| ETD | unknown | yes | 1 unknown · 1 yes | |
Bloomin' Brands Stock Rockets 40% as Higher Checks Rescue Outlook | ||||
| BLMN | yes | yes | 2/2 yes | |
BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates | ||||
| BIOA | unknown | yes | 1 unknown · 1 yes | |
| LLY | unknown | no | 1 unknown · 1 no | |
| NVS | unknown | no | 1 unknown · 1 no | |
Why BrightView Holdings Stock Tanked Today | ||||
| BV | no | no | 2/2 no | |
GXO Logistics Fell Sharply Today, But a Turnaround Could Be Coming | ||||
| GXO | no | no | 2/2 no | |
| XPO | unknown | no | 1 unknown · 1 no | |
Why Chemours Plunged on Wednesday | ||||
| CC | no | no | 2/2 no | |
Grab (GRAB) Stock Looks Fairly Priced Despite Record Results And Buyback | ||||
| GRAB | yes | yes | 2/2 yes | |
Here's Why Oracle's Stock Continues to Lag its Peers Like Amazon, Microsoft, and Alphabet | ||||
| AMZN | unknown | unknown | 2/2 unknown | |
| GOOG | unknown | unknown | 2/2 unknown | |
| GOOGL | unknown | unknown | 2/2 unknown | |
| MSFT | unknown | yes | 1 unknown · 1 yes | |
| ORCL | unknown | no | 1 unknown · 1 no | |
SpaceX Sets Sights on T-Mobile, AT&T and Verizon Customers | ||||
| T | unknown | no | 1 unknown · 1 no | |
Bloomin Brands Inc (BLMN) (Q2 2026) Earnings Call Highlights: Positive Comps and Raised ... | ||||
| BLMN | yes | yes | 2/2 yes | |
Kaltura Inc (KLTR) (Q2 2026) Earnings Call Highlights: Record AI Deals and Raised Guidance ... | ||||
| KLTR | yes | yes | 2/2 yes | |
| No rows match — try clearing filters. | ||||
Show the remaining 130 articles (judged unknown or not about the stock) — kept because no-signal is also a result.
| stock | gpt-4.1-nano | gpt-4o-mini | panel | |
|---|---|---|---|---|
8-K filing — Tejon Ranch Co | ||||
| TRC | unknown | unknown | 2/2 unknown | |
Latham Group, Inc. to Participate at Upcoming Conference in August 2026 | ||||
| SWIM | unknown | unknown | 2/2 unknown | |
VoIP-Pal Granted Leave to File Amended Antitrust Complaint in D.C. Litigation | ||||
| T | unknown | unknown | 2/2 unknown | |
8-K filing — Parker-Hannifin Corp | ||||
| PH | unknown | unknown | 2/2 unknown | |
These Analysts Revise Their Forecasts On Coupang Following Q2 Results | ||||
| CPNG | unknown | unknown | 2/2 unknown | |
8-K filing — Suburban Propane Partners Lp | ||||
| SPH | · | · | ||
8-K filing — Viatris Inc | ||||
| VTRS | unknown | unknown | 2/2 unknown | |
8-K filing — Agenus Inc | ||||
| AGEN | · | · | ||
Stephens & Co. Reiterates Equal-Weight on Portillos, Maintains $5 Price Target | ||||
| PTLO | unknown | unknown | 2/2 unknown | |
OpenAI's Rogue Agents Built Their Own Message Boards and Grew Paranoid of Each Other Months Before Hugging Face Breach, Staffers Reveal | ||||
| META | unknown | no | 1 unknown · 1 no | |
8-K filing — Cars.com Inc. | ||||
| CARS | unknown | unknown | 2/2 unknown | |
8-K filing — Intellia Therapeutics, Inc. | ||||
| NTLA | · | · | ||
8-K filing — Lantheus Holdings, Inc. | ||||
| LNTH | · | · | ||
Healthcare Chatbots Market Size to Hit USD 11.13 Billion by 2035 Driven by Generative AI and Virtual Healthcare Adoption | SNS Insider | ||||
| AMZN | unknown | unknown | 2/2 unknown | |
| BIDU | unknown | unknown | 2/2 unknown | |
| IBM | unknown | unknown | 2/2 unknown | |
| MSFT | unknown | unknown | 2/2 unknown | |
CORRECTION: CACI International Ticker Is CACI Not CAAA | ||||
| CACI | unknown | unknown | 2/2 unknown | |
8-K filing — Sabre Corp | ||||
| SABR | unknown | unknown | 2/2 unknown | |
Wall Street's Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields | ||||
| CLX | unknown | unknown | 2/2 unknown | |
| CPB | unknown | unknown | 2/2 unknown | |
| HRL | unknown | unknown | 2/2 unknown | |
8-K filing — PepGen Inc. | ||||
| PEPG | unknown | unknown | 2/2 unknown | |
8-K filing — Ati Inc | ||||
| ATI | unknown | unknown | 2/2 unknown | |
8-K filing — Sunrise Realty Trust, Inc. | ||||
| SUNS | unknown | unknown | 2/2 unknown | |
8-K filing — Distribution Solutions Group, Inc. | ||||
| DSGR | · | · | ||
8-K filing — Biovie Inc. | ||||
| BIVI | unknown | unknown | 2/2 unknown | |
8-K filing — Payoneer Global Inc. | ||||
| PAYO | · | · | ||
8-K filing — Sunstone Hotel Investors, Inc. | ||||
| SHO | · | · | ||
8-K filing — Climb Bio, Inc. | ||||
| CLYM | unknown | unknown | 2/2 unknown | |
8-K filing — Ingles Markets Inc | ||||
| IMKTA | unknown | unknown | 2/2 unknown | |
8-K filing — Itt Inc. | ||||
| ITT | unknown | unknown | 2/2 unknown | |
8-K filing — Lexicon Pharmaceuticals, Inc. | ||||
| LXRX | unknown | unknown | 2/2 unknown | |
8-K filing — MACOM Technology Solutions Holdings, Inc. | ||||
| MTSI | unknown | unknown | 2/2 unknown | |
8-K filing — Collegium Pharmaceutical, Inc | ||||
| COLL | unknown | unknown | 2/2 unknown | |
Sunrise Realty Trust, Inc. Announces Financial Results for the Second Quarter 2026 | ||||
| SUNS | unknown | unknown | 2/2 unknown | |
8-K filing — Cronos Group Inc. | ||||
| CRON | · | · | ||
8-K filing — Optimum Communications, Inc. | ||||
| OPTU | · | · | ||
Elon Musk Has a Message for Jeff Bezos' Blue Origin After It Solved the New Glenn Mystery— 'Hope You...' | ||||
| AMZN | unknown | unknown | 2/2 unknown | |
| SPCX | unknown | unknown | 2/2 unknown | |
8-K filing — Installed Building Products, Inc. | ||||
| IBP | unknown | unknown | 2/2 unknown | |
8-K filing — RE/MAX Holdings, Inc. | ||||
| RMAX | · | · | ||
8-K filing — Cheniere Energy, Inc. | ||||
| LNG | · | · | ||
8-K filing — Curtiss Wright Corp | ||||
| CW | unknown | unknown | 2/2 unknown | |
8-K filing — Genie Energy Ltd. | ||||
| GNE | unknown | unknown | 2/2 unknown | |
8-K filing — Compass Therapeutics, Inc. | ||||
| CMPX | · | · | ||
8-K filing — Priority Technology Holdings, Inc. | ||||
| PRTH | · | · | ||
8-K filing — Nuvation Bio Inc. | ||||
| NUVB | · | · | ||
Domestic Metals to Commence Drill Program at Smart Creek Project, Montana | ||||
| RIO | unknown | unknown | 2/2 unknown | |
Where Will Rocket Lab Stock Be in 5 Years? | ||||
| RKLB | unknown | unknown | 2/2 unknown | |
8-K filing — Six Flags Entertainment Corporation/NEW | ||||
| FUN | · | · | ||
Trading Halt: Halt status updated at 7:25:00 AM ET: Quotation Resumption: News and Resumption Times | ||||
| VISN | unknown | unknown | 2/2 unknown | |
8-K filing — Safe Pro Group Inc. | ||||
| SPAI | · | · | ||
8-K filing — Conocophillips | ||||
| COP | unknown | unknown | 2/2 unknown | |
8-K filing — Tarsus Pharmaceuticals, Inc. | ||||
| TARS | · | · | ||
8-K filing — Nuveen Churchill Direct Lending Corp. | ||||
| NCDL | unknown | unknown | 2/2 unknown | |
8-K filing — Appian Corp | ||||
| APPN | unknown | unknown | 2/2 unknown | |
Mangoceuticals’ Merger Partner Nuclea Energy Signs MoU With New Mining To Study Behind-The-Meter Use Of Modular Reactors To Power High-Density Computing | ||||
| MGRX | unknown | unknown | 2/2 unknown | |
8-K filing — Cogent Communications Holdings, Inc. | ||||
| CCOI | unknown | unknown | 2/2 unknown | |
8-K filing — Sotera Health Co | ||||
| SHC | unknown | unknown | 2/2 unknown | |
8-K filing — Driven Brands Holdings Inc. | ||||
| DRVN | unknown | unknown | 2/2 unknown | |
8-K filing — Precision Biosciences Inc | ||||
| DTIL | · | · | ||
8-K filing — FrontView REIT, Inc. | ||||
| FVR | · | · | ||
Market-Moving news for August 6th | ||||
| APP | unknown | unknown | 2/2 unknown | |
| SOUN | unknown | unknown | 2/2 unknown | |
8-K filing — Harrow, Inc. | ||||
| HROW | · | · | ||
8-K filing — Fiserv Inc | ||||
| FISV | · | · | ||
8-K filing — Immunovant, Inc. | ||||
| IMVT | unknown | unknown | 2/2 unknown | |
8-K filing — Aclaris Therapeutics, Inc. | ||||
| ACRS | unknown | unknown | 2/2 unknown | |
8-K filing — Versant Media Group, Inc. | ||||
| VSNT | · | · | ||
8-K filing — Roivant Sciences Ltd. | ||||
| ROIV | unknown | unknown | 2/2 unknown | |
8-K filing — Xeris Biopharma Holdings, Inc. | ||||
| XERS | unknown | unknown | 2/2 unknown | |
8-K filing — Sionna Therapeutics, Inc. | ||||
| SION | unknown | unknown | 2/2 unknown | |
8-K filing — Ironwood Pharmaceuticals Inc | ||||
| IRWD | unknown | unknown | 2/2 unknown | |
8-K filing — Tarsus Pharmaceuticals, Inc. | ||||
| TARS | · | · | ||
8-K filing — CareCloud, Inc. | ||||
| CCLD | unknown | unknown | 2/2 unknown | |
8-K filing — Bausch & Lomb Corp | ||||
| BLCO | · | · | ||
8-K filing — REGENXBIO Inc. | ||||
| RGNX | · | · | ||
8-K filing — Scholar Rock Holding Corp | ||||
| SRRK | unknown | unknown | 2/2 unknown | |
8-K filing — Tarsus Pharmaceuticals, Inc. | ||||
| TARS | · | · | ||
8-K filing — SharonAI Holdings Inc. | ||||
| SHAZ | · | · | ||
8-K filing — Teleflex Inc | ||||
| TFX | · | · | ||
8-K filing — Vistance Networks, Inc. | ||||
| VISN | · | · | ||
8-K filing — Datadog, Inc. | ||||
| DDOG | · | · | ||
8-K filing — Commerce.com, Inc. | ||||
| CMRC | unknown | unknown | 2/2 unknown | |
Assessment of AAE-C1INH Disease Burden and Validation of Clinical Trial Endpoints Published in Frontiers in Immunology | ||||
| PHVS | unknown | unknown | 2/2 unknown | |
Bullish releases July 2026 monthly metrics | ||||
| BLSH | unknown | unknown | 2/2 unknown | |
History Says Investing $400 per Month in This ETF Could Set You Up for Life. Here's How. | ||||
| AAPL | unknown | unknown | 2/2 unknown | |
| AMZN | unknown | unknown | 2/2 unknown | |
| GOOG | unknown | unknown | 2/2 unknown | |
| GOOGL | unknown | unknown | 2/2 unknown | |
| META | unknown | unknown | 2/2 unknown | |
| MSFT | unknown | unknown | 2/2 unknown | |
| NVDA | unknown | unknown | 2/2 unknown | |
| TSLA | unknown | no | 1 unknown · 1 no | |
Investors Send SoftBank Stock 4.4% Lower Even as Profit Beats Estimates | ||||
| INTC | · | · | ||
Investors Send SoftBank Stock 4.4% Lower Even as Profit Beats Estimates | ||||
| INTC | unknown | no | 1 unknown · 1 no | |
Prediction: Nvidia CEO Jensen Huang Will Shock Wall Street on Aug. 26 | ||||
| NVDA | unknown | unknown | 2/2 unknown | |
RESULTS OF ANNUAL GENERAL MEETING HELD ON AUGUST 6, 2026 | ||||
| CYD | unknown | unknown | 2/2 unknown | |
BlockComp and Dragonfly Partner to Launch the Third Annual Crypto Compensation Survey, Setting a New Standard for Industry Benchmarks | ||||
| DFLI | unknown | unknown | 2/2 unknown | |
Transaction in Own Shares | ||||
| SHEL | · | · | ||
Is Nvidia a Millionaire-Maker Stock? | ||||
| NVDA | unknown | unknown | 2/2 unknown | |
Intel and ByteDance stakes help SoftBank beat expectations | ||||
| INTC | · | · | ||
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons | ||||
| NVO | unknown | unknown | 2/2 unknown | |
Tutor Perini Corp (TPC) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised Guidance ... | ||||
| T | · | · | ||
Tutor Perini Corp (TPC) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised Guidance ... | ||||
| T | unknown | no | 1 unknown · 1 no | |
Bloomin' Brands, Inc. 2026 Q2 - Results - Earnings Call Presentation | ||||
| BLMN | unknown | unknown | 2/2 unknown | |
Peabody Energy Corporation (BTU) Facing Securities Class Action Related to Surprise Centurion Problems – HBSS | ||||
| BTU | · | · | ||
Gran Tierra Energy (GTE) Q2 2026 Earnings Call | ||||
| GTE | unknown | unknown | 2/2 unknown | |
Inseego Q2 Earnings Call Highlights | ||||
| NOK | unknown | no | 1 unknown · 1 no | |
Bloomin' Brands (BLMN) Following Q2 Earnings And Guidance Lift Is The Stock Already Priced In | ||||
| BLMN | unknown | unknown | 2/2 unknown | |
Tutor Perini (TPC) Q2 Earnings and Revenues Top Estimates | ||||
| T | · | · | ||
Tutor Perini (TPC) Q2 Earnings and Revenues Top Estimates | ||||
| T | unknown | no | 1 unknown · 1 no | |
ATN International (ATNI) Reports Q2 Loss, Tops Revenue Estimates | ||||
| ONDS | unknown | no | 1 unknown · 1 no | |
AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Lags Revenue Estimates | ||||
| ANIP | no | no | 2/2 no | |
Inter & Co. Inc. (INTR) Q2 Earnings and Revenues Beat Estimates | ||||
| ANTA | unknown | unknown | 2/2 unknown | |
Hyliion Investor News: If You Have Suffered Losses in Hyliion Holdings Corp. (NYSE American: HYLN), You Are Encouraged to Contact The Rosen Law Firm About Your Rights | ||||
| HYLN | · | · | ||
Ensign Investor News: If You Have Suffered Losses in The Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights | ||||
| ENSG | · | · | ||
Tarsus to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 | ||||
| TARS | unknown | unknown | 2/2 unknown | |
Tutor Perini (NYSE:TPC) Reports Strong Q2 CY2026 | ||||
| T | · | · | ||
Tutor Perini (NYSE:TPC) Reports Strong Q2 CY2026 | ||||
| T | unknown | no | 1 unknown · 1 no | |
Gildan Investor News: If You Have Suffered Losses in Gildan Activewear Inc. (NYSE: GIL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights | ||||
| GIL | · | · | ||
Allstate (ALL) Beats Q2 Earnings Estimates | ||||
| ESNT | · | · | ||
Allstate (ALL) Beats Q2 Earnings Estimates | ||||
| ESNT | unknown | unknown | 2/2 unknown | |
Materion Corporation Q2 2026 Earnings Call Summary | ||||
| MTRN | unknown | unknown | 2/2 unknown | |
2 Energy Dividend Stocks to Buy in August for Steady Income | ||||
| CVX | unknown | unknown | 2/2 unknown | |
Bragar Eagel & Squire, P.C. is Investigating Replimune Group Inc. on Behalf of Replimune Stockholders and Encourages Investors to Contact the Firm | ||||
| REPL | · | · | ||
Portillo’s 2Q Revenue Climbs, Teases New Long-Term Growth Strategy | ||||
| BLMN | unknown | no | 1 unknown · 1 no | |
UiPath (PATH) Registers a Bigger Fall Than the Market: Important Facts to Note | ||||
| PATH | · | · | ||
LGI Homes, Inc. Reports July 2026 Home Closings | ||||
| LGIH | unknown | unknown | 2/2 unknown | |
Bloomin' Brands, Inc. Q2 2026 Earnings Call Summary | ||||
| BLMN | unknown | unknown | 2/2 unknown | |
SpaceX, Alphabet, Nvidia, Micron, AMD, Uber, CVS, Lilly, and More Stocks That Explain Today’s Market | ||||
| INTC | · | · | ||
Wondering what's happening in today's after-hours session? | ||||
| INLF | unknown | unknown | 2/2 unknown | |
| RITR | unknown | unknown | 2/2 unknown | |
| YXT | unknown | unknown | 2/2 unknown | |
Transocean Ltd. Provides Quarterly Fleet Status Report | ||||
| EQNR | unknown | unknown | 2/2 unknown | |
| RIG | unknown | unknown | 2/2 unknown | |
Tutor Perini Reports Strong Second Quarter 2026 Financial Results; Raises 2026 Adjusted EPS Guidance; Increases Quarterly Dividend 50% | ||||
| T | · | · | ||
Tutor Perini Reports Strong Second Quarter 2026 Financial Results; Raises 2026 Adjusted EPS Guidance; Increases Quarterly Dividend 50% | ||||
| T | unknown | no | 1 unknown · 1 no | |
Flotek Industries, Inc. (FTK) Q2 2026 Earnings Call Transcript | ||||
| FTK | unknown | unknown | 2/2 unknown | |
Dow Makes More New Highs Despite AI Drag: Stock Market Today | ||||
| T | · | · | ||
Dow Makes More New Highs Despite AI Drag: Stock Market Today | ||||
| T | unknown | unknown | 2/2 unknown | |
Kaltura, Inc. (KLTR) Q2 2026 Earnings Call Transcript | ||||
| KLTR | unknown | unknown | 2/2 unknown | |
Which stocks are moving on Wednesday? | ||||
| AMIX | unknown | unknown | 2/2 unknown | |
| AMWL | unknown | unknown | 2/2 unknown | |
| BJDX | unknown | unknown | 2/2 unknown | |
| BLMN | unknown | unknown | 2/2 unknown | |
| CISS | unknown | unknown | 2/2 unknown | |
| GWAV | unknown | unknown | 2/2 unknown | |
| INLF | · | · | ||
| JLHL | · | · | ||
| KLTR | unknown | unknown | 2/2 unknown | |
| LMB | unknown | unknown | 2/2 unknown | |
| RITR | unknown | unknown | 2/2 unknown | |
| SPPL | unknown | unknown | 2/2 unknown | |
| SUJA | unknown | unknown | 2/2 unknown | |
| SXTC | unknown | unknown | 2/2 unknown | |
| TYGO | unknown | unknown | 2/2 unknown | |
| USNA | unknown | unknown | 2/2 unknown | |
| ZYBT | unknown | unknown | 2/2 unknown | |
SpaceX, Alphabet, Nvidia, Micron, AMD, Uber, CVS, Lilly, and More Stocks That Explain Today’s Market | ||||
| INTC | unknown | unknown | 2/2 unknown | |
Azio AI Holdings (AZIO) Is 'One to Watch' | ||||
| T | · | · | ||
Azio AI Holdings (AZIO) Is 'One to Watch' | ||||
| T | unknown | no | 1 unknown · 1 no | |
| No rows match — try clearing filters. | ||||